{"id":765775,"date":"2023-06-23T16:08:20","date_gmt":"2023-06-23T20:08:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/"},"modified":"2023-06-23T16:08:20","modified_gmt":"2023-06-23T20:08:20","slug":"vbi-vaccines-announces-results-of-annual-general-meeting-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/","title":{"rendered":"VBI Vaccines Announces Results of Annual General Meeting"},"content":{"rendered":"

<\/p>\n

VBI Vaccines Announces Results of Annual General Meeting<\/b><\/p>\n

CAMBRIDGE, Mass.–(BUSINESS WIRE<\/a>)–
\nVBI Vaccines Inc. (Nasdaq: VBIV) (“VBI” or the “Company”), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the voting results from its annual general meeting of shareholders held on June 23, 2023 (the “Meeting”).\n<\/p>\n

\nThe total number of common shares of the Company (“Common Shares”) represented by shareholders (“Shareholders”) present in person or represented by proxy at the Meeting was an aggregate of 5,560,730 Common Shares, representing 64.60% of VBI’s issued and outstanding Common Shares as of the record date for the Meeting, April 26, 2023.\n<\/p>\n

\nThe voting results with respect to each of the following eight director nominees, as described in the Company’s proxy statement dated May 1, 2023 (the “Proxy Statement”), all of whom previously served as directors of the Company, were as follows:\n<\/p>\n\n\n\n\n\n\n\n\n\n\n
\n

Nominee<\/b><\/p>\n<\/td>\n

\u00a0<\/td>\n\n

Votes For<\/b><\/p>\n<\/td>\n

\u00a0<\/td>\n\n

%<\/b><\/p>\n<\/td>\n

\u00a0<\/td>\n\n

Votes Withheld<\/b><\/p>\n<\/td>\n

\u00a0<\/td>\n\n

%<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

\nSteven Gillis\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n2,149,267\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n84.82%\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n384,590\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n15.18%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDamian Braga\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n2,277,929\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n89.90%\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n255,931\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n10.10%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nJoanne Cordeiro\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n2,327,969\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n91.87%\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n205,888\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n8.13%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nMichel De Wilde\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n2,276,500\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n89.84%\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n257,357\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n10.16%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nVaughn Himes\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n2,284,875\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n90.17%\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n248,982\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n9.83%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nBlaine H. McKee\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n2,333,881\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n92.11%\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n199,977\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n7.89%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nJeffrey R. Baxter\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n2,204,880\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n87.02%\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n328,977\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n12.98%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nNell Beattie\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n2,253,500\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n88.94%\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n280,358\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n11.06%\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nEach of the other matters put forward before the Shareholders for consideration and approval at the Meeting, as described in the Proxy Statement, were duly approved by the requisite number of votes. The Shareholders voted in favor of appointing EisnerAmper LLP as VBI’s independent registered public accounting firm for the ensuing year and authorizing the audit committee of VBI’s board of directors to fix its remuneration. The Shareholders also approved, each on an advisory basis, the frequency of holding an advisory vote on executive compensation every three years, and the compensation paid to the Company\u2019s named executive officers as set forth in the Proxy Statement.\n<\/p>\n

\nAdditional information regarding the results of all matters voted upon at the Meeting may be found in the Company’s SEC and SEDAR filings.\n<\/p>\n

About VBI Vaccines Inc.<\/b><\/p>\n

\nVBI Vaccines Inc. (\u201cVBI\u201d) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (\u201cVLPs\u201d), including a proprietary enveloped VLP (\u201ceVLP\u201d) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, coronaviruses, and cytomegalovirus (CMV), as well as aggressive cancers including glioblastoma (GBM). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. For more information, visit www.vbivaccines.com<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230623028843\/en\/<\/a><\/span><\/p>\n

VBI Contact
\n<\/b>
Nicole Anderson
\n
Director, Corporate Communications & IR
\n
Phone: (617) 830-3031 x124
\n
Email: IR@vbivaccines.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Massachusetts<\/p>\n

INDUSTRY KEYWORDS:<\/b> Research Infectious Diseases FDA Clinical Trials Other Health Biotechnology Pharmaceutical Health Science Oncology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

VBI Vaccines Announces Results of Annual General Meeting CAMBRIDGE, Mass.–(BUSINESS WIRE)– VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI” or the “Company”), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the voting results from its annual general meeting of shareholders held on June 23, 2023 (the “Meeting”). The total number of common shares of the Company (“Common Shares”) represented by shareholders (“Shareholders”) present in person or represented by proxy at the Meeting was an aggregate of 5,560,730 Common Shares, representing 64.60% of VBI’s issued and outstanding Common Shares as of the record date for the Meeting, April 26, 2023. The voting results with respect to each of the following eight director nominees, … <\/p>\n

Continue reading “VBI Vaccines Announces Results of Annual General Meeting”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-765775","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nVBI Vaccines Announces Results of Annual General Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VBI Vaccines Announces Results of Annual General Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VBI Vaccines Announces Results of Annual General Meeting CAMBRIDGE, Mass.–(BUSINESS WIRE)– VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI” or the “Company”), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the voting results from its annual general meeting of shareholders held on June 23, 2023 (the “Meeting”). The total number of common shares of the Company (“Common Shares”) represented by shareholders (“Shareholders”) present in person or represented by proxy at the Meeting was an aggregate of 5,560,730 Common Shares, representing 64.60% of VBI’s issued and outstanding Common Shares as of the record date for the Meeting, April 26, 2023. The voting results with respect to each of the following eight director nominees, … Continue reading "VBI Vaccines Announces Results of Annual General Meeting"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-23T20:08:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230623028843r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"VBI Vaccines Announces Results of Annual General Meeting\",\"datePublished\":\"2023-06-23T20:08:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/\"},\"wordCount\":471,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230623028843r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/\",\"name\":\"VBI Vaccines Announces Results of Annual General Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230623028843r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2023-06-23T20:08:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230623028843r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230623028843r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vbi-vaccines-announces-results-of-annual-general-meeting-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VBI Vaccines Announces Results of Annual General Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VBI Vaccines Announces Results of Annual General Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/","og_locale":"en_US","og_type":"article","og_title":"VBI Vaccines Announces Results of Annual General Meeting - Market Newsdesk","og_description":"VBI Vaccines Announces Results of Annual General Meeting CAMBRIDGE, Mass.–(BUSINESS WIRE)– VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI” or the “Company”), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the voting results from its annual general meeting of shareholders held on June 23, 2023 (the “Meeting”). The total number of common shares of the Company (“Common Shares”) represented by shareholders (“Shareholders”) present in person or represented by proxy at the Meeting was an aggregate of 5,560,730 Common Shares, representing 64.60% of VBI’s issued and outstanding Common Shares as of the record date for the Meeting, April 26, 2023. The voting results with respect to each of the following eight director nominees, … Continue reading \"VBI Vaccines Announces Results of Annual General Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/","og_site_name":"Market Newsdesk","article_published_time":"2023-06-23T20:08:20+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230623028843r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"VBI Vaccines Announces Results of Annual General Meeting","datePublished":"2023-06-23T20:08:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/"},"wordCount":471,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230623028843r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/","name":"VBI Vaccines Announces Results of Annual General Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230623028843r1&sid=flmnd&distro=nx&lang=en","datePublished":"2023-06-23T20:08:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230623028843r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230623028843r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vbi-vaccines-announces-results-of-annual-general-meeting-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"VBI Vaccines Announces Results of Annual General Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/765775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=765775"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/765775\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=765775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=765775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=765775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}